Metabolic-Associated Fatty Liver
VIDEO: Green tea extract, turmeric among supplements associated with liver injury
PHILADELPHIA — In this video, Nancy S. Reau, MD, FAASLD, AGAF, discusses the impact certain herbal and dietary supplements may have on the liver, especially among patients with underlying liver disease.
The Emerging Role of Glucagon-Like Peptide-1 Receptor Agonists for the Treatment of Metabolic Dysfunction-Associated Steatohepatitis
This activity is supported by an educational grant from Novo Nordisk.
Hyperferritinemia may indicate progression of liver disease, poor prognosis in MAFLD
CHARLOTTE, N.C. — Elevated ferritin correlated with an increased prevalence of cirrhosis — but not congestive heart failure — in patients with metabolic dysfunction-associated fatty liver disease, according to a presenter here.
Progress made toward understanding best noninvasive tests for NASH, fibrosis diagnosis
To streamline and validate diagnosis of and clinical trials in non-alcoholic steatohepatitis, one group is on a mission to determine the best non-invasive tests for all physicians to use, according to a presentation.
Hepatic steatosis common in patients with severe hypertriglyceridemia
Among patients with severe hypertriglyceridemia who underwent MRI proton density fat fraction, clinically meaningful hepatic steatosis appeared to be common, according to a presenter at the National Lipid Association Scientific Sessions.